Cas13 can be harnessed for RNA knockdown and editing in mammalian cells, opening up a range of applications in RNA biology.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Abudayyeh, O.O. et al. Nature 550, 280–284 (2017).
Cox, D.B.T. et al. Science 358, 1019–1027 (2017).
Abudayyeh, O.O. et al. Science 353, aaf557 (2016).
Liu, L. et al. Cell 168, 121–134.e12 (2017).
Knott, G.J. et al. Nat. Struct. Mol. Biol. 24, 825–833 (2017).
East-Seletsky, A. et al. Nature 538, 270–273 (2016).
Gootenberg, J.S. et al. Science 356, 438–442 (2017).
Fukuda, M. et al. Sci. Rep. 7, 41478 (2017).
Kuttan, A. & Bass, B.L. Proc. Natl. Acad. Sci. USA 109, E3295–E3304 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Kim, V. RNA-targeting CRISPR comes of age. Nat Biotechnol 36, 44–45 (2018). https://doi.org/10.1038/nbt.4054
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.4054